FibroGen | EFFECT: Others
FibroGen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(2.4%)
FibroGen | S-3: Registration statement for specified transactions by certain issuers
FibroGen | 8-K: Current report
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Wettig Thane
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Adib Deyaa
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Graham Juan
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Chung Christine
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Wettig Thane
FibroGen | 8-K: Current report
FibroGen | 4: Statement of changes in beneficial ownership of securities-Director Schoeneck James A
FibroGen | 4: Statement of changes in beneficial ownership of securities-Director Lema Gerald
FibroGen | 4: Statement of changes in beneficial ownership of securities-Director Ho Maykin
FibroGen | 4: Statement of changes in beneficial ownership of securities-Director Cravatt Benjamin
FibroGen | 4: Statement of changes in beneficial ownership of securities-Director Brennan Aoife
FibroGen | 4: Statement of changes in beneficial ownership of securities-Director Blaug Suzanne
FibroGen | 10-Q: Quarterly report
FibroGen | 8-K: FibroGen Reports First Quarter 2024 Financial Results
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Wettig Thane
FibroGen | ARS: Annual Report to Security Holders
No Data